ARTICLE | Company News
Illumina taking out Pacific Biosciences for $1.2B
November 9, 2018 5:58 PM UTC
Illumina Inc. (NASDAQ:ILMN) is acquiring fellow genomics company Pacific Biosciences of California Inc. (NASDAQ:PACB) for $8 per share in cash, or about $1.2 billion.
The price is a 77% premium to Pacific Biosciences' close of $4.51 on Nov. 1, when the companies announced the deal after market close. Pacific added $3.05 (68%) to $7.56 on Nov. 2...